Can Red Light Protect Your Eyes and Improve Sleep? The New Frontier of Photobiomodulation

In this Deep Dive, Dr. Mike Belkowski returns to the roots of The Energy Code by examining two newly published reviews on red light therapy. The first explores photobiomodulation for ocular aging and eye diseases, including age-related macular degeneration, dry eye, and childhood myopia. The second evaluates whether PBM can improve sleep quality by influencing brain metabolism, cerebral blood flow, neural networks, and melatonin-related pathways. Dr. Mike breaks down how light interacts with mitochondrial cytochrome c oxidase, improves electron flow and ATP production, and may restore bioenergetics in two of the body’s most energy-demanding tissues: the brain and retina. The episode also examines the LIGHTSITE clinical trials, repeated low-level red-light therapy for myopia, transcranial PBM for sleep, extra-pineal melatonin production, and why proper wavelength, irradiance, and dosage remain essential. The emerging message is that red light may be far more than a tool for skin, pain, and muscle recovery. It may represent an investigational strategy for restoring cellular energy in the tissues responsible for how clearly we see and how deeply we sleep. (Educational content only, not medical advice.) - Article Discussed in Episode: Near-Infrared and Red-Light Photobiomodulation for Ocular Aging and Diseases: A Narrative Review Photobiomodulation and sleep quality: systematic review and meta-analysis - Key Quotes From Dr. Mike: “Many of the conditions we associate with aging and declining function may ultimately be manifestations of an underlying energy problem.” “We are witnessing a bioenergetic tipping point where mitochondrial decay dictates the pace of systemic aging.” “The human eye is an ideal target for PBM due to its optical accessibility and the immense energy demands of the retina.” “Brief exposures to red light can slow the progression of myopia in children.” “PBM may help restore homeostatic sleep pressure — the biological need to sleep... Red and near-infrared wavelengths have the capability of improving our systemic melatonin production.” “The gastrointestinal tract is likely the largest source of melatonin in the body.” “If mitochondria contribute to melatonin production, all of a sudden full-body red light therapy becomes imperative for normalizing circadian rhythm.” - Key Points ⚡ Two new reviews examine photobiomodulation for ocular aging and disease and for sleep quality. ⚡ The brain and retina are among the body’s most energy-demanding tissues, making them especially vulnerable to mitochondrial decline. ⚡ Red and near-infrared light interact with cytochrome c oxidase, helping displace inhibitory nitric oxide, restore oxygen utilization, and increase ATP production. ⚡ PBM follows a Goldilocks dose response: too little may do nothing, while excessive light can become inhibitory or pro-oxidative. ⚡ The LIGHTSITE clinical trials reported modest but statistically significant visual-acuity gains of roughly four to five ETDRS letters in patients with dry age-related macular degeneration. ⚡ Ocular PBM may also reduce drusen burden and potentially slow geographic atrophy, although further clinical confirmation is needed. ⚡ Repeated low-level red-light therapy is being studied as a way to slow the abnormal eyeball elongation responsible for childhood myopia. ⚡ Ocular protocols differ by goal: age-related macular degeneration often uses multiple red, amber, and near-infrared wavelengths, while myopia protocols typically use red light alone. ⚡ Wavelength determines penetration depth; device strength primarily determines how quickly a therapeutic dose is delivered. ⚡ High-powered panels should not be used close to the eyes without carefully adjusting distance, exposure time, and irradiance. ⚡ Transcranial PBM may support sleep by influencing adenosine signaling, cerebral metabolism, astrocytes, and prefrontal and thalamocortical networks. ⚡ Current sleep findings are statistically promising, but may not yet represent clinically meaningful improvements. ⚡ Red and near-infrared light may also support sleep indirectly by improving mitochondrial function and extra-pineal melatonin synthesis. ⚡ Melatonin is produced throughout the body — including the retina, gastrointestinal tract, skin, immune cells, cardiovascular tissues, and mitochondria — not only in the pineal gland. ⚡ PBM should currently be viewed as a promising adjunctive and investigational tool, not a replacement for established medical care. - Episode timeline 00:00–03:17 — Return to the podcast’s red-light roots; introduction to two new reviews on sleep and ocular PBM 03:18–05:54 — Why the retina and brain are ideal — and very different — targets for red and near-infrared light 05:55–06:44 — Research context and Francisco Gonzalez-Lima’s involvement in both papers 06:45–08:48 — The invisible cellular engine: mitochondrial decline, aging, and PBM as a nonthermal bioenergetic intervention 08:49–10:24 — The mitochondrial master switch: cytochrome c oxidase, nitric oxide displacement, oxygen utilization, ATP, and the biphasic dose response 10:25–13:28 — Saving sight: the LIGHTSITE clinical program, ETDRS letter gains, drusen reduction, and dry macular degeneration 13:29–16:25 — The myopia paradox: how low-level red light may slow abnormal eye elongation in children 16:27–17:56 — Comparing ocular protocols: multi-wavelength PBM for macular degeneration versus red-only treatment for myopia 17:58–21:20 — Practical eye-treatment considerations: irradiance, distance, exposure time, low-powered devices, and screen-light balancing 21:21–22:46 — The prefrontal “off switch”: transcranial PBM, adenosine signaling, brain-network efficiency, and sleep quality 22:47–23:21 — Research limitations: statistical significance versus clinically meaningful improvement 23:22–26:49 — Extra-pineal melatonin: the retina, gut, skin, immune cells, reproductive tissues, and mitochondria 26:50–27:38 — How consistent PBM, sunlight, evening darkness, and circadian lighting may work together to support sleep 27:40–29:35 — Final synthesis: PBM as an investigational adjunct, future applications in spaceflight, and illuminated healthcare - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight Labs:  Website Instagram   BioLight: Website Instagram YouTube Facebook